Here are four observations:
1. The notice of allowance is for the company’s application for its “Devices and Methods for the Regeneration of Bony Defects.”
2. This is the second allowance for a collagen/bioactive glass device in the last 90 days.
3. NovaBone Products recently received patent issuance for the first allowance establishing intellectual property for Novabone.
4. The privately held company is a focuses on developing NovaBone, a bioactive synthetic bone graft.
More articles on devices:
39 spine, orthopedic devices receive FDA 510(k) clearance in August
5 new device launches & releases — September 28, 2015
Stryker Navigation’s SpineMask tracker cuts down incisions during spine surgery: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
